Clinical Trial Update: Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of durvalumab and BVAC-C in cervical cancer patients who failed first-line platinum-based chemotherapy is ongoing with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• BVAC-C (BVAC-C)
• Durvalumab (durvalumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN